I migliori medici per il trattamento di Lung cancer stage 4 - TOP-35 medici

1,100 procedures and 28 years of experience in medical oncology – Serkan Keskin specializes in breast cancer treatment. He holds first-place rankings in national proficiency exams.

• Trained in oncology at Istanbul University Institute
• Member of ASCO, ESMO, and Turkish oncologist societies
• Awarded Best Poster at the 19th National Cancer Congress
• Uses chemotherapy, targeted therapy, and immunotherapy
• Focuses on internal medicine with hospital-level training

Dr. Eda Tanrikulu is a leading medical oncologist at Anadolu Medical Center, specializing in the use of chemotherapy and new treatment protocols.

• 16 years of professional medical experience
• Specializes in medical oncology and chemotherapy for cancer
• Placed third in Turkey's competitive oncology specialization exam
• Managed the oncology department at Haydarpaşa Numune Training and Research Hospital
• Participated in numerous international clinical trials for new cancer treatments

Dr. Solak specializes in lung cancer treatment with fellowship training at Hacettepe University Cancer Institute – one of Turkey's leading oncology centers.

• Completed residency at Istanbul Sisli Etfal Teaching and Research Hospital
• Trained at The University of Texas MD Anderson Cancer Center
• Handles complex cases of breast, testicular, ovarian, and gastrointestinal cancers
• Member of Turkish Medical Association

Prof. Sezer Sağlam specializes in medical oncology with a focus on gastrointestinal and lung cancers at Gayrettepe Florence Nightingale Hospital.

• Professor of Medical Oncology since 2016
• Fellowship-trained at Istanbul University Medical Faculty
• Member of ESMO, ASCO, and Turkish Medical Oncology Association
• Over 20 years of experience in oncology

Assoc. Prof. Abdullah Sakin leads the Medical Oncology Department at Medipol Bahçelievler Hospital, specializing in advanced lung cancer cases.

• Head of Medical Oncology at Yüzüncü Yıl University
• Trained in Medical Oncology at Istanbul Okmeydanı Research Hospital
• Extensive experience in both academic and clinical settings
• Specializes in complex stage 4 lung cancer treatments

Professor Doctor Sefik Igdem specializes in Radiation Oncology, with advanced training in Truebeam Stx and Halcyons technologies.

• Over 25 years of experience in radiation oncology
• Expertise in head and neck cancers
• Professor at T.R Demiroğlu Bilim University
• Uses conformal treatments for precise radiation therapy

Professor Yesim Yildirim specializes in cancer immunotherapy and targeted therapies for lung cancer, with over 80 international publications to her name.

• Member of the European Society of Medical Oncology (ESMO)
• Professor at Halic University, combining clinical practice with academic research
• Expertise in precision medicine for lung and breast cancers
• Completed advanced oncology training at Rambam Medical Centre in Israel

Specialist Dr. Rahib Hasanov brings international experience from Houston Methodist Hospital and specializes in advanced lung cancer treatments, including immunotherapies and targeted therapies.

• Completed Medical Oncology fellowship at Marmara University
• Experienced in personalized treatment approaches for lung cancer
• Regularly treats patients from across Europe and the US
• Practices at Hisar Hospital Intercontinental

Prof. Sezer Saglam specializes in medical oncology with a focus on gastrointestinal cancers at Gayrettepe Florence Nightingale Hospital.

• Professor of Medical Oncology since 2016
• Completed Medical Oncology Fellowship at Istanbul University
• Member of ESMO, ASCO, and Turkish Medical Oncology Association
• Specializes in gastrointestinal oncology since 2005

Assoc.Prof. Altan Kır specializes in Thoracic and Robotic Surgery, focusing on lung cancer at Anadolu Medical Center since 2007.

• Member of Turkish Thoracic Surgery Society
• Member of European Society of Thoracic Surgeons
• Member of Thorax Society

Associate Professor Dr. Yusuf Acikgoz brings global expertise from Ohio State University to lung cancer treatment at Lokman Hekim University Ankara Hospital.

• Specializes in advanced medical oncology with a focus on lung cancer
• Involved in international phase III clinical trials like CheckMate-649 and Fortitude-101
• Certified in Good Clinical Practice and Human Subjects Protection
• Member of American Society of Clinical Oncology (ASCO) and Turkish Society of Medical Oncology

Dr. Yildiz has published extensively on lung cancer and neuroendocrine tumors, with research featured in Medical Oncology and other peer-reviewed journals.

• Specializes in neuroendocrine tumors and lung cancer
• Published multiple case studies on rare cancer presentations
• Works at Medipol Mega University Hospital
• Member of oncology research teams

900+ lung cancer treatments performed – Saban Sec is a Clinical Oncologist with extensive expertise in lung cancer at Valued Med Hub Hospitals.

• 13 years of medical oncology experience
• Member of the Turkish Medical Oncology Association
• Specialist in lung cancer and other thoracic malignancies
• Published research on prognostic factors in non-small cell lung cancer

Over a decade of experience treating lung cancer, specializing in breast, lung, and gastrointestinal cancers at Istinye Liv University Hospital.

• Associate Professor since 2016, with extensive academic and clinical training
• Specializes in internal medicine and oncology, ensuring comprehensive care
• Worked at Ankara Oncology Clinic and Erzurum Regional Training and Research Hospital

Professor Bilir specializes in lung cancer treatment, combining clinical expertise with academic research at Sakarya University.

• Board-certified in medical oncology with over 15 years of experience
• Member of ASCO and ESMO – stays updated with global oncology standards
• Completed research fellowship at Northeastern University in Boston
• Currently pursuing Ph.D. in inorganic chemistry to enhance cancer treatment approaches

Professor Gul Alco specializes in radiation oncology for lung cancer at Medipol Acibadem District Hospital.

• Over 20 years of experience in radiation oncology
• Professor at Istanbul Medipol University
• Trained at Istanbul University and Kadir Has University
• Worked at Şişli Florence Nightingale Hospital

Dr. Ozden specializes in treating advanced lung cancer at VM Medical Park Pendik Hospital, with extensive training and practice in medical oncology.

• Graduated from Istanbul University Cerrahpaşa Faculty of Medicine
• Completed medical oncology subspecialty at Kocaeli University
• Over a decade of experience in internal medicine and oncology
• Worked at Şırnak State Hospital focusing on medical oncology

Assoc. Prof. Atakan Topçu, M.D., is a medical oncologist at Medipol University and Medipol Acıbadem Regional Hospital. He treats solid tumors, including lung, breast, colorectal, gastric, and neuroendocrine cancers. His work also covers targeted therapies, immunotherapy, geriatric oncology, and cancer-related malnutrition, cachexia, and sarcopenia.

He has authored more than 50 peer-reviewed papers. Recent work includes a 2024 Frontiers in Medicine study on geriatric syndromes and a 2023 Future Oncology paper on sarcopenia and anxiety in lung cancer. He has also published on the CONUT score in breast cancer and on malnutrition in HER2-negative metastatic gastric cancer.

Dr. Topçu serves on the Editorial Board of BMC Cancer. He is a member of the Turkish Society of Medical Oncology, ESMO, and the Turkish Geriatrics Society. Education and training: M.D., Uludağ University; residency in Internal Medicine, Marmara University; fellowship in Medical Oncology, Bezmialem Vakıf University.

Assoc. Prof. Nail Paksoy brings expertise from Istanbul University Oncology Institute and leads the Medical Oncology team at Medipol Bahçelievler Hospital.

• ESMO Board Certified in Medical Oncology – a prestigious European qualification
• Participated in 8+ international clinical trials for lung cancer treatments
• Published research on ALK-positive NSCLC and other advanced cancers
• Specializes in precision oncology and targeted therapies for stage 4 cases